Logo image of MAPS

WM TECHNOLOGY INC (MAPS) Stock Fundamental Analysis

USA - NASDAQ:MAPS - US92971A1097 - Common Stock

1.11 USD
-0.03 (-2.63%)
Last: 10/14/2025, 8:00:00 PM
1.11 USD
0 (0%)
After Hours: 10/14/2025, 8:00:00 PM
Fundamental Rating

6

Overall MAPS gets a fundamental rating of 6 out of 10. We evaluated MAPS against 282 industry peers in the Software industry. While MAPS has a great health rating, its profitability is only average at the moment. MAPS scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, MAPS could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year MAPS was profitable.
In the past year MAPS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: MAPS reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: MAPS reported negative operating cash flow in multiple years.
MAPS Yearly Net Income VS EBIT VS OCF VS FCFMAPS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

MAPS's Return On Assets of 4.66% is fine compared to the rest of the industry. MAPS outperforms 72.34% of its industry peers.
The Return On Equity of MAPS (16.60%) is better than 84.04% of its industry peers.
MAPS's Return On Invested Capital of 7.28% is fine compared to the rest of the industry. MAPS outperforms 76.95% of its industry peers.
Industry RankSector Rank
ROA 4.66%
ROE 16.6%
ROIC 7.28%
ROA(3y)-20.01%
ROA(5y)-12.91%
ROE(3y)-301.64%
ROE(5y)-167.98%
ROIC(3y)N/A
ROIC(5y)N/A
MAPS Yearly ROA, ROE, ROICMAPS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

With a decent Profit Margin value of 4.77%, MAPS is doing good in the industry, outperforming 66.31% of the companies in the same industry.
MAPS's Profit Margin has declined in the last couple of years.
MAPS has a Operating Margin of 7.82%. This is in the better half of the industry: MAPS outperforms 70.57% of its industry peers.
MAPS has a better Gross Margin (95.10%) than 99.65% of its industry peers.
In the last couple of years the Gross Margin of MAPS has remained more or less at the same level.
Industry RankSector Rank
OM 7.82%
PM (TTM) 4.77%
GM 95.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-49.04%
PM growth 5YN/A
GM growth 3Y-0.28%
GM growth 5YN/A
MAPS Yearly Profit, Operating, Gross MarginsMAPS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MAPS is destroying value.
The number of shares outstanding for MAPS has been increased compared to 1 year ago.
MAPS has more shares outstanding than it did 5 years ago.
MAPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MAPS Yearly Shares OutstandingMAPS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
MAPS Yearly Total Debt VS Total AssetsMAPS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

MAPS has an Altman-Z score of 1.91. This is not the best score and indicates that MAPS is in the grey zone with still only limited risk for bankruptcy at the moment.
MAPS's Altman-Z score of 1.91 is in line compared to the rest of the industry. MAPS outperforms 46.81% of its industry peers.
MAPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.91
ROIC/WACC0.65
WACC11.26%
MAPS Yearly LT Debt VS Equity VS FCFMAPS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

MAPS has a Current Ratio of 2.40. This indicates that MAPS is financially healthy and has no problem in meeting its short term obligations.
MAPS has a Current ratio of 2.40. This is in the better half of the industry: MAPS outperforms 69.15% of its industry peers.
MAPS has a Quick Ratio of 2.40. This indicates that MAPS is financially healthy and has no problem in meeting its short term obligations.
MAPS's Quick ratio of 2.40 is fine compared to the rest of the industry. MAPS outperforms 69.15% of its industry peers.
Industry RankSector Rank
Current Ratio 2.4
Quick Ratio 2.4
MAPS Yearly Current Assets VS Current LiabilitesMAPS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 275.00% over the past year.
Measured over the past years, MAPS shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.09% on average per year.
The Revenue has been growing slightly by 2.37% in the past year.
Measured over the past years, MAPS shows a decrease in Revenue. The Revenue has been decreasing by -1.50% on average per year.
EPS 1Y (TTM)275%
EPS 3Y-55.61%
EPS 5Y-8.09%
EPS Q2Q%600%
Revenue 1Y (TTM)2.37%
Revenue growth 3Y-1.5%
Revenue growth 5YN/A
Sales Q2Q%-2.3%

3.2 Future

MAPS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.84% yearly.
The Revenue is expected to grow by 8.96% on average over the next years. This is quite good.
EPS Next Y133.14%
EPS Next 2Y57.39%
EPS Next 3Y42.84%
EPS Next 5YN/A
Revenue Next Year-4.51%
Revenue Next 2Y0.33%
Revenue Next 3Y5.44%
Revenue Next 5Y8.96%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MAPS Yearly Revenue VS EstimatesMAPS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M 250M
MAPS Yearly EPS VS EstimatesMAPS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1

9

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.93, the valuation of MAPS can be described as very cheap.
Based on the Price/Earnings ratio, MAPS is valued cheaply inside the industry as 93.26% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.50. MAPS is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 6.40, the valuation of MAPS can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MAPS indicates a rather cheap valuation: MAPS is cheaper than 96.45% of the companies listed in the same industry.
MAPS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.99.
Industry RankSector Rank
PE 7.93
Fwd PE 6.4
MAPS Price Earnings VS Forward Price EarningsMAPS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

98.58% of the companies in the same industry are more expensive than MAPS, based on the Enterprise Value to EBITDA ratio.
96.45% of the companies in the same industry are more expensive than MAPS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.81
EV/EBITDA 3.61
MAPS Per share dataMAPS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

MAPS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MAPS's earnings are expected to grow with 42.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.06
PEG (5Y)N/A
EPS Next 2Y57.39%
EPS Next 3Y42.84%

0

5. Dividend

5.1 Amount

MAPS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

WM TECHNOLOGY INC

NASDAQ:MAPS (10/14/2025, 8:00:00 PM)

After market: 1.11 0 (0%)

1.11

-0.03 (-2.63%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners45.03%
Inst Owner Change0%
Ins Owners19.85%
Ins Owner Change-0.01%
Market Cap174.51M
Analysts80
Price Target2.66 (139.64%)
Short Float %1.73%
Short Ratio1.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)34.8%
Min EPS beat(2)-1.96%
Max EPS beat(2)71.57%
EPS beat(4)1
Avg EPS beat(4)5.92%
Min EPS beat(4)-43.98%
Max EPS beat(4)71.57%
EPS beat(8)2
Avg EPS beat(8)-207.91%
EPS beat(12)4
Avg EPS beat(12)-192.13%
EPS beat(16)7
Avg EPS beat(16)-47.49%
Revenue beat(2)0
Avg Revenue beat(2)-1.33%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)-0.26%
Revenue beat(4)2
Avg Revenue beat(4)0.16%
Min Revenue beat(4)-2.4%
Max Revenue beat(4)2.68%
Revenue beat(8)3
Avg Revenue beat(8)-2.03%
Revenue beat(12)6
Avg Revenue beat(12)-1.18%
Revenue beat(16)8
Avg Revenue beat(16)-1.21%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-11.11%
EPS NY rev (3m)-11.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.93%
Valuation
Industry RankSector Rank
PE 7.93
Fwd PE 6.4
P/S 0.95
P/FCF 7.81
P/OCF 5.23
P/B 3.31
P/tB N/A
EV/EBITDA 3.61
EPS(TTM)0.14
EY12.61%
EPS(NY)0.17
Fwd EY15.62%
FCF(TTM)0.14
FCFY12.81%
OCF(TTM)0.21
OCFY19.11%
SpS1.17
BVpS0.34
TBVpS-0.11
PEG (NY)0.06
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.66%
ROE 16.6%
ROCE 9.22%
ROIC 7.28%
ROICexc 11.72%
ROICexgc 42.43%
OM 7.82%
PM (TTM) 4.77%
GM 95.1%
FCFM 12.17%
ROA(3y)-20.01%
ROA(5y)-12.91%
ROE(3y)-301.64%
ROE(5y)-167.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-49.04%
PM growth 5YN/A
GM growth 3Y-0.28%
GM growth 5YN/A
F-Score7
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 57.87%
Cap/Sales 5.98%
Interest Coverage 250
Cash Conversion 99.95%
Profit Quality 255.3%
Current Ratio 2.4
Quick Ratio 2.4
Altman-Z 1.91
F-Score7
WACC11.26%
ROIC/WACC0.65
Cap/Depr(3y)92.5%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.69%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)275%
EPS 3Y-55.61%
EPS 5Y-8.09%
EPS Q2Q%600%
EPS Next Y133.14%
EPS Next 2Y57.39%
EPS Next 3Y42.84%
EPS Next 5YN/A
Revenue 1Y (TTM)2.37%
Revenue growth 3Y-1.5%
Revenue growth 5YN/A
Sales Q2Q%-2.3%
Revenue Next Year-4.51%
Revenue Next 2Y0.33%
Revenue Next 3Y5.44%
Revenue Next 5Y8.96%
EBIT growth 1Y-17.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29.73%
EBIT Next 3Y10.07%
EBIT Next 5Y9.64%
FCF growth 1Y231.2%
FCF growth 3Y18.23%
FCF growth 5YN/A
OCF growth 1Y996.43%
OCF growth 3Y16.68%
OCF growth 5YN/A